| Product ID | 72934-1064_887a6d0f-d339-48b9-e053-2a95a90af2a0 |
| NDC | 72934-1064 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5% |
| Generic Name | Dapsone 8.5% / Niacinamide 2% / Spironolactone 5% |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-10 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida, LLC |
| Substance Name | SPIRONOLACTONE; DAPSONE; NIACINAMIDE |
| Active Ingredient Strength | 5 g/100g; g/100g; g/100g |
| Pharm Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Sulfone [EPC],Sulfones [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |